The Rising Prevalence Of Candidiasis Infection To Boost The Candidiasis Market Growth

Candidiasis Market
Candidiasis Market

The Candidiasis Market by Route of Administration (Injection, Ointment, and Oral), Drug Type (Polyene, Azole, Echinocandin, and Other Drug Types), Anatomy Type (Oral Candidiasis, Vulvovaginal Candidiasis, Cutaneous Candidiasis, Invasive Candidiasis, and Systemic Candidiasis), End-users (Hospitals and Clinics, Retail Pharmacies, and Other End-users), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) Size, Share, Outlook, and Opportunity Analysis, 2023-2030

The global Candidiasis Market is estimated to be valued at reach US$ 986.5 million in 2021 and is expected to exhibit a CAGR of 4.39 % over the forecast period, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

Candidiasis is a fungal inflammation caused by a yeast known as Candida. Few classes of Candida can led to inflammation in individuals; the most frequent infection is Candida albicans. Candida usually stays on the dermis and in the body, such as the throat, mouth, skin, and vagina, without leading to any difficulty.. Candida can lead to inflammation if it grows out of control or if it goes deep inside the body.

Competitive Landscape:

Key players involved in the growth of the global Candidiasis Market are SCYNEXIS, Inc., Mycovia Pharmaceuticals, Inc., Basilea Pharmaceutica Ltd, Pfizer Inc, Astellas Pharma Inc., NovaDigm Therapeutics, and Viatris Inc.

Market Key Drivers:

The rising prevalence of Candidiasis infection is expected to augment the growth of global Candidiasis for Market. For instance, as per report by Nature in June 2021, there have been 2,739casese per 100,000 individuals suffering from vulvovaginal candidiasis in Zimbabwe.

The rising cases of vaginitis is projected to propel the growth of the global Candidiasis for Market. For instance, as per PLOS One in April 2022 vaginitis was known to affect 30% of vulvovaginal patients.

Covid-19 Impact Analysis:

The Covi-19 outbreak had adversely affected the growth of global Candidiasis Market mostly in the initial stage of pandemic owing to the strict imposition of lockdown and shutdowns, worldwide trade was affected severely, and the supply chain of pharma was interrupted, which impeded the sales of candidiasis drugs and treatment.

Key Takeaways:

The global candidiasis for market is anticipated to exhibit a CAGR of 4.39 % during the forecast period due to rising R&D for the expansion of treatment for the RVV or VVC. For instance, in February 2021, SCYNEXIS, Inc., collaborated with Amplity Health, to introduce Brexafemme in the U.S. for the treatment of vaginal yeast infection.

Among regions, North America, Europe, and Asia Pacific are expected to witness robust growth in the global Candidiasis Market due to rising prevalence of RVV or VCC, increasing R&D, quick approvals and product launches. For instance, as per PubMed, out of 12.3 million women in the IBM MarketScan database 149,934 women were diagnosed with VVC in U.S.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more